Prothena Corp. plc Stock
Prothena Corp. plc Stock
We can see a decrease in the price for Prothena Corp. plc. Compared to yesterday it has lost €0.000 (-1.820%).
With 16 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 26 € there is potential for a 220.99% increase which would mean more than doubling the current price of 8.1 € for Prothena Corp. plc.
Our community identified positive and negative aspects for Prothena Corp. plc stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Prothena Corp. plc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Prothena Corp. plc in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prothena Corp. plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prothena Corp. plc | -1.820% | 0.621% | -10.497% | -45.270% | -44.138% | -84.809% | -28.947% |
| Ardelyx Inc. | -1.890% | -0.081% | 3.250% | 11.858% | -0.826% | 131.663% | -14.721% |
| Krystal Biotech | 0.850% | 7.068% | 15.304% | 39.043% | 41.327% | 190.676% | - |
| Evolus Inc | -2.480% | -0.840% | 2.609% | -42.157% | -43.810% | -10.606% | 81.204% |
Comments
Prothena (NASDAQ:PRTA) had its price target raised by analysts at HC Wainwright from $20.00 to $30.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) was given a new $20.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) had its price target lowered by analysts at Piper Sandler from $81.00 to $15.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat